Literature DB >> 23601229

Oral mucositis in patients receiving low-dose methotrexate therapy for rheumatoid arthritis: report of 2 cases and literature review.

Matthias Troeltzsch1, Gerhard von Blohn, Stefanie Kriegelstein, Timothy Woodlock, Volker Gassling, Ronald Berndt, Markus Troeltzsch.   

Abstract

BACKGROUND: The differential diagnosis of ulcerative oral lesions is diverse. This report discusses the rare causes of oral mucosal ulceration and suggests approaches for diagnosis and treatment.
METHODS: Two cases of methotrexate-induced stomatitis in patients receiving low dose methotrexate for rheumatoid arthritis are presented with a review of the current literature. In case 1, mucositis was caused by an unintended methotrexate overdose. In case 2, oral lesions were the result of chronic methotrexate toxicity. The treatment for methotrexate-induced mucositis required hospitalization in case 1, methotrexate discontinuation in both cases and oral folic acid supplementation in case 2.
RESULTS: In both cases, the mucositis healed and no relapse was observed.
CONCLUSION: Mucositis may be an early sign of systemic conditions, and dental providers are often the first doctors involved in the assessment of oral mucosal diseases. Meticulous questioning of the patient's history and the physical examination is important for elucidating the underlying cause.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23601229     DOI: 10.1016/j.oooo.2012.12.008

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  6 in total

Review 1.  Oral pathology in inflammatory bowel disease.

Authors:  Miranda Muhvić-Urek; Marija Tomac-Stojmenović; Brankica Mijandrušić-Sinčić
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Methotrexate-induced mucositis with extra-mucosal involvement after acidental overdose.

Authors:  Greice Rampon; Caroline Henkin; Valéria Magalhães Jorge; Hiram Larangeira de Almeida
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

3.  Effect of taxifolin on methotrexate-induced oxidative and inflammatory oral mucositis in rats: biochemical and histopathological evaluation.

Authors:  Zeynep Bayramoglu; Behzad Mokhtare; Ali Sefa Mendil; Taha Abdulkadir Coban; Renad Mammadov; Seval Bulut; Zeynep Suleyman; Halis Suleyman
Journal:  J Appl Oral Sci       Date:  2022-09-19       Impact factor: 3.144

4.  In vitro inhibition of HUVECs by low dose methotrexate - insights into oral adverse events.

Authors:  Tobias Annussek; Thomas Szuwart; Johannes Kleinheinz; Cathrin Koiky; Kai Wermker
Journal:  Head Face Med       Date:  2014-05-22       Impact factor: 2.151

5.  Atypical methotrexate ulcerative stomatitis with features of lymphoproliferative like disorder: Report of a rare ciprofloxacin-induced case and review of the literature.

Authors:  Nikolaos Katsoulas; Evanthia Chrysomali; Evangelia Piperi; Georgia Levidou; Alexandra Sklavounou-Andrikopoulou
Journal:  J Clin Exp Dent       Date:  2016-12-01

6.  Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.

Authors:  Anja Weidmann; Amy C Foulkes; N Kirkham; N J Reynolds
Journal:  Dermatol Ther (Heidelb)       Date:  2014-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.